T315I mutation with lymphoblasts in a newly diagnosed patient with chronic-phase chronic myeloid leukemia

Leuk Lymphoma. 2019 Jun;60(6):1591-1594. doi: 10.1080/10428194.2018.1548704. Epub 2019 Jan 16.

Authors

Kenji Kimura¹, Shokichi Tsukamoto¹, Koji Takaishi¹, Yusuke Isshiki¹, Kensuke Kayamori¹, Yutaro Hino¹, Nagisa Ohshima-Hasegawa¹, Shio Mitsukawa^{1

2}, Yusuke Takeda¹, Naoya Mimura^{1

2}, Masahiro Takeuchi¹, Chikako Ohwada¹, Tohru Iseki^{1

2}, Chiaki Nakaseko^{1

3}, Emiko Sakaida¹

Affiliations

¹ a Department of Hematology , Chiba University Hospital , Chiba , Japan.
² b Department of Transfusion Medicine and Cell Therapy , Chiba University Hospital , Chiba , Japan.
³ c Department of Hematology , International University of Health and Welfare School of Medicine , Narita , Japan.

PMID: 31161870
DOI: 10.1080/10428194.2018.1548704

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Amino Acid Substitution*
Biomarkers
Biopsy
Bone Marrow / pathology*
Combined Modality Therapy
Cytogenetic Analysis
DNA Mutational Analysis
Fatal Outcome
Female
Fusion Proteins, bcr-abl / genetics*
Humans
Immunophenotyping
Leukemia, Myeloid, Chronic-Phase / diagnosis*
Leukemia, Myeloid, Chronic-Phase / genetics*
Leukemia, Myeloid, Chronic-Phase / therapy
Middle Aged
Mutation*

Substances

Biomarkers
Fusion Proteins, bcr-abl